Driehaus Capital Management LLC Olema Pharmaceuticals, Inc. Transaction History

Driehaus Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$3.22 - $9.65 $278,932 - $835,931	86,625 New	86,625 $782,000
Q2 2021 Aug 16, 2021	SELL	$21.15 - $36.14 $3.63 Million - $6.21 Million	-171,762 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$27.81 - $53.64 $2.82 Million - $5.45 Million	-101,573 Reduced 37.16%	171,762 $5.7 Million
Q4 2020 Feb 16, 2021	BUY	$37.09 - $54.5 $10.1 Million - $14.9 Million	273,335 New	273,335 $13.1 Million

145

58.3M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $248M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.